N-Vax SRL
N-Vax reported total assets of 45,605 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
The score of N-Vax shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +68 % Total assets +83 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
N-Vax's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
N-Vax's financial analysis
- Solvency44.9%sector median: 45.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of N-Vax
N-Vax's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0773.653.885
- VAT number
- BE0773653885
- Peppol
- Registered · 0208:0773653885 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Sep 2021
- Registered office
- 2170 Antwerp
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Other specialised construction activities n.e.c. (NACE 43990)
N-Vax (SRL) has been based in Antwerp since 2021, active in: other specialised construction activities n.e.c.. For 2025, it reports a net loss of 3,657 € and equity of 20,475 €; its revenue is not published. Its solvency stands at 44.9%, below the median of its sector (45.6%).
Guide: How to check a Belgian building contractor before works →
Companies similar to N-Vax
Companies in the same business, of comparable size and area, outside its group.
- Project Copyright Other specialised construction activities n.e.c. Bornem · balance sheet 75,008 €
- Mawi Pools Other specialised construction activities n.e.c. Malle · balance sheet 92,061 €
- Mywell Other specialised construction activities n.e.c. Brasschaat · balance sheet 139,701 €
- Poolmaster Other specialised construction activities n.e.c. Schilde · balance sheet 36,312 €
- SeGi Jobs Other specialised construction activities n.e.c. Brecht · balance sheet 45,940 €
- KaPe Invest Other specialised construction activities n.e.c. Antwerp · balance sheet 44,526 €
- Jaro BAT Other specialised construction activities n.e.c. Anderlecht · balance sheet 39,761 €
- Dulo Pools Other specialised construction activities n.e.c. Kruisem · balance sheet 48,584 €
Frequently asked questions about N-Vax
What is the revenue of N-Vax?
N-Vax files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of N-Vax?
In Belgium, the VAT number is the company number prefixed with BE: BE0773653885 for N-Vax, if the company is VAT-registered. Its company number (CBE) is 0773.653.885.
Where is the registered office of N-Vax?
According to the CBE register, the registered office of N-Vax is in 2170 Antwerp.
What is the equity of N-Vax?
At the close of the 2025 financial year, the equity of N-Vax amounts to 20,475 €, a solvency of 44.9% of total assets.
Who manages N-Vax?
The register lists 1 active mandates at N-Vax. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of N-Vax
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →